Mistaken fear of measles shot has ‚devastating‘ effect

 

Rochester, Minnesota, USA (August 30, 2011) – More than 150 cases of measles have been reported in the United States already this year and there have been similar outbreaks in Europe, a sign the disease is making an alarming comeback. The reappearance of the potentially deadly virus is the result of unfounded fears about a link between the measles shot and autism that have turned some parents against childhood vaccination, says Gregory Poland, M.D. (http://www.mayoclinic.org/bio/10966366.html), of Mayo Clinic. In the September issue of Mayo Clinic Proceedings (http://www.mayoclinicproceedings.com), Dr. Poland urges doctors to review extensive scientific research that has found no connection between the measles-mumps-rubella (MMR) vaccine and autism.

 

Fears about the MMR vaccine were sparked in 1998 by researcher Andrew Wakefield, M.D., in the British medical journal The Lancet (http://www.sciencedirect.com/science/journal/01406736). Dr. Wakefield’s study was later found fraudulent by the British General Medical Council and the paper was retracted. Even so, suspicions about the vaccine — as well as its additives such as thimerosal — have persisted, gaining steam with the public through celebrity advocates and widespread media coverage.

 

"A rising portion of the population is deciding not to immunize their children because of this controversy, and these children are now susceptible to the measles (http://www.mayoclinic.com/health/measles/DS00331) virus," says Dr. Poland, Mary Lowell Leary Professor of Medicine and director of the Mayo Clinic Vaccine Research Group.

 

"The results have been devastating," Dr. Poland says. "The campaign against the vaccine has caused great harm to public health across multiple nations, even though it has no scientific basis. There have been over 20 studies, spanning two decades, conducted in several countries. Not one has found scientific evidence of a connection between autism spectrum disorders and MMR vaccine."

 

Measles remains the most contagious infectious disease humans can get. It kills roughly three of every thousand people infected. Due to the vaccine’s effectiveness and successful immunization programs worldwide, indigenous cases of the disease had been eliminated in the U.S. and on track to be eradicated, similar to smallpox.

 

Dr. Poland recommends that doctors, patients, and the media become educated about the research on the research that already has been conducted and help rectify the misinformation. A major report released by the Institute of Medicine last week supports Dr. Poland’s claims of no connection between the MMR vaccine and autism (http://www.mayoclinic.com/health/autism/DS00348/DSECTION=causes).

 

"Just as significantly," he adds, "we need to direct appropriate and significant funds to determine what’s really causing autism in our children."

 

 

A peer-reviewed journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. Articles are available online at www.mayoclinicproceedings.com

 

 

About Mayo Clinic

 

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about

 


 

Mayo Clinic, 30.08.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…